About this trial
Last updated 3 years ago
Study ID
CT008
Status
Not yet recruiting
Type
Interventional
Phase
Early Phase 1
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 2 years ago
What is this trial about?
This is a pilot study to determine the usefulness of new brachytherapy device that utilizes
active components (palladium-103) of standard devices in a novel configuration, which may
benefit basal cell and squamous cell carcinoma patients by providing conformal radiation
therapy to the surface of the skin.
What are the participation requirements?
Inclusion Criteria
- subject signed informed consent
- Confirmed superficial or nodular basal cell or squamous cell carcinoma
- Biopsy proven on chest, stomach, back, arms, legs, feet (trunk and extremities)
- >5 mm of residual tumor
- tumors < 3 cm
- Capable of complying with Patient Release Instructions
Exclusion Criteria
- Is unable or unwilling to comply with the protocol requirements
- Pregnant or breast feeding
- Metastases